Comments
Loading...

Context Therapeutics

CNTXNASDAQ
$2.04
-0.15-6.85%
At Close: -
$2.03
-0.01-0.49%
After Hours: 6:00 PM EDT
15 minutes delayed
Link Immunotherapeutics, Inc sold assets to Context Therapeutics (CNTX) on Wednesday, July 10, 2024

Context Therapeutics (NASDAQ:CNTX) Stock, Earnings Estimates, EPS, And Revenue

Context Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 7
EPS Estimate
$-0.070
Quarterly Revenue Estimate
Annual Revenue
(as of Mar 31)

Analyze the earnings history of Context Therapeutics using advanced sorting and filters.

Get Alert
CNTX
Context Therapeutics
-$0.31-$0.07$0.0008/07/2024Get Alert
CNTX
Context Therapeutics
-$0.40-$0.38-$0.2339.47%$0.00$0.0005/08/2024Get Alert
CNTX
Context Therapeutics
-$0.22-$0.35-$0.42-20.00%$0.00$0.0003/21/2024Get Alert
CNTX
Context Therapeutics
-$0.24-$0.37$0.00$0.0011/09/2023Get Alert
CNTX
Context Therapeutics
-$0.25-$0.31$0.00$0.0008/09/2023Get Alert
CNTX
Context Therapeutics
-$0.22-$0.40$0.00$0.0005/10/2023Get Alert
CNTX
Context Therapeutics
-$0.30-$0.22$0.00$0.0003/22/2023Get Alert
CNTX
Context Therapeutics
-$4.00-$0.24$0.0011/09/2022Get Alert
CNTX
Context Therapeutics
-$14.18-$0.25$0.00$0.0008/11/2022Get Alert
CNTX
Context Therapeutics
-$2.55-$0.22$0.00$0.0005/11/2022Get Alert
CNTX
Context Therapeutics
-$0.61-$0.30$0.00$0.0003/23/2022Get Alert

Context Therapeutics (CNTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-08$-0.23$-0.3839.5 %
Dec 20232024-03-21$-0.42$-0.35-20.0 %

Context Therapeutics (CNTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?

A

Context Therapeutics (CNTX) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Context Therapeutics (NASDAQ:CNTX)?

A

The Actual EPS was $-0.23, which beat the estimate of $-0.38.

Q

What were Context Therapeutics’s (NASDAQ:CNTX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch